Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $57,109.53 today based on a price of $563.10 for REGN at the time of writing.

Regeneron presents an interesting investment case. Its valuation doesn't fully capture Dupixent's strength or its pipeline potential. Bears worry about Eylea's patent cliff, but this seems priced in.

Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and ...

Target has promised not to raise costs for back-to-school items this year, offering a sigh of relief to customers who enjoyed 2024 prices.

Fintel reports that on July 22, 2025, JP Morgan downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Overweight to Neutral. Analyst Price Forecast Suggests 725.97% Upside As of July 17, ...

Major indices were in the green earlier on Wednesday as traders digested more bank earnings and another key inflation report.

New York State Common Retirement Fund trimmed its Regeneron stake by 5% in Q1, selling over 6,800 shares worth millions.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Shares of Levi Strauss jumped Friday, a day after the denim retailer topped fiscal second-quarter estimates and lifted its full-year outlook, leading JPMorgan analysts to bump their price target.